Clinical trial Recruiting at 1 site Observational

Identifying genetic causes of developmental diseases

Official title: Identification of the Molecular and/or Pathophysiological Bases of Rare Diseases of Genetic Origin (or Rare Forms of Frequent Diseases Suspected of Being of Genetic Origin).

Run by Centre Hospitalier Universitaire Dijon · NCT03287193 · Data updated 2026-11-12

This study is trying to find the genetic causes of over 3000 developmental disorders by looking at blood samples from patients to help families understand these conditions better.

Quick facts

Study typeObservational
SexAll
Enrollment850 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations1 site (Dijon)
StatusRecruiting
StartedMarch 13, 2017
Main results expectedMarch 2027
Study endsDecember 2027
Registry record updatedDecember 8, 2025
Trial IDNCT03287193 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include fetuses, children, and adults with unexplained developmental anomalies.

Probably not a fit

Patients without national health insurance coverage may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify the molecular and pathophysiological bases of developmental anomalies, which encompass over 3000 different conditions. By utilizing next-generation sequencing and analyzing blood samples from patients, the study seeks to uncover genetic factors that contribute to these disorders. Despite advancements in genetic research, many individuals with severe developmental anomalies remain undiagnosed, highlighting the need for this investigation. The findings could enhance genetic counseling for affected families and improve understanding of these complex conditions.

Why it matters

Potential benefit: If successful, this study could lead to better genetic diagnoses and counseling for patients with developmental anomalies.

How similar studies have gone: Other studies utilizing next-generation sequencing have shown promise in identifying genetic causes of rare diseases, suggesting a potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

-Patients (children or adults) with a suspected rare disease (or rare form of a common disease) of genetic origin for which the molecular basis is not known, or for which the understanding of the physiopathological mechanism is imperfectly known.

OR

-Foetuses with developmental abnormalities for which the molecular basis is not known, or for which the understanding of the physiopathological mechanism is imperfectly known.

OR

* Apparently healthy relatives or controls AND
* Consent of the patient or his/her legal representative
* Suitable level of understanding

Exclusion Criteria:

* Patients without national health insurance cover

Where it's running

  • Chu Dijon Bourogne
    Dijon, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.